Human Health Holdings Limited (HKG:1419)
Hong Kong · Delayed Price · Currency is HKD 0.8000
+0.0550 (7.38%)
Aug 11, 2026, 6:13 PM HKT
Human Health Holdings Ratios and Metrics
Market cap in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 304 | 315 | 387 | 721 | 619 | 380 | |
Market Cap Growth | -17.53% | -18.63% | -46.32% | 16.56% | 63.00% | 40.84% |
Enterprise Value | -51 | -33 | 63 | 358 | 412 | 318 |
Last Close Price | 0.80 | 0.80 | 0.95 | 1.57 | 1.13 | 0.63 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 10.96 | 11.96 | 16.01 | 3.99 | 1.65 | 2.63 |
Forward PE | - | 18.97 | 18.97 | 18.97 | 18.97 | 18.97 |
PS Ratio | 0.45 | 0.49 | 0.66 | 0.72 | 0.55 | 0.58 |
PB Ratio | 0.39 | 0.40 | 0.51 | 0.89 | 0.83 | 0.93 |
P/TBV Ratio | 0.43 | 0.45 | 0.53 | 0.93 | 0.88 | 1.02 |
P/FCF Ratio | 2.45 | 3.47 | - | 1.24 | 2.82 | 5.31 |
P/OCF Ratio | 2.31 | 3.20 | 29.32 | 1.09 | 2.09 | 4.44 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | - | - | 0.11 | 0.36 | 0.37 | 0.49 |
EV/EBITDA Ratio | - | - | 1.61 | 1.11 | 0.94 | 2.04 |
EV/EBIT Ratio | - | - | 3.47 | 1.17 | 0.96 | 2.18 |
EV/FCF Ratio | - | - | - | 0.62 | 1.88 | 4.46 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.15 | 0.17 | 0.19 | 0.23 | 0.25 | 0.16 |
Debt / EBITDA Ratio | 1.17 | 1.37 | 1.70 | 0.48 | 0.38 | 0.31 |
Debt / FCF Ratio | 0.97 | 1.48 | - | 0.32 | 0.86 | 0.94 |
Net Debt / Equity Ratio | -0.45 | -0.39 | -0.45 | -0.57 | -0.11 | -0.23 |
Net Debt / EBITDA Ratio | -6.41 | -6.03 | -8.78 | -1.42 | -0.19 | -0.61 |
Net Debt / FCF Ratio | -2.86 | -3.36 | 13.05 | -0.79 | -0.37 | -1.34 |
Asset Turnover | 0.64 | 0.61 | 0.51 | 0.83 | 1.27 | 1.26 |
Inventory Turnover | 15.88 | 12.17 | 10.59 | 17.51 | 28.62 | 21.34 |
Quick Ratio | 2.76 | 2.57 | 2.58 | 2.13 | 2.30 | 2.14 |
Current Ratio | 3.14 | 2.89 | 2.84 | 2.28 | 2.43 | 2.24 |
Return on Equity (ROE) | 3.69% | 3.44% | 3.07% | 23.33% | 65.15% | 43.17% |
Return on Assets (ROA) | 2.08% | 1.78% | 0.98% | 15.85% | 30.27% | 17.55% |
Return on Invested Capital (ROIC) | 7.09% | 5.99% | 4.28% | 46.07% | 74.18% | 46.43% |
Return on Capital Employed (ROCE) | 4.00% | 3.50% | 2.20% | 33.60% | 50.00% | 34.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 11, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | 9.14% | 8.36% | 6.25% | 25.08% | 60.66% | 38.06% |
FCF Yield | 40.74% | 28.83% | -6.79% | 80.46% | 35.45% | 18.82% |
Dividend Yield | 3.75% | 3.75% | 2.95% | 10.22% | 26.51% | 18.93% |
Payout Ratio | 0.05% | 40.35% | 251.06% | 62.96% | 12.14% | 0.38% |
Total Shareholder Return | 4.08% | 3.75% | 2.95% | 10.22% | 26.51% | 18.93% |